CS
Candriam SCA Portfolio holdings
AUM
$17.3B
This Quarter Return
+4.05%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$8B
AUM Growth
+$8B
(+2.4%)
Cap. Flow
-$814M
Cap. Flow
% of AUM
-10.17%
Top 10 Holdings %
Top 10 Hldgs %
19.85%
Holding
870
New
73
Increased
308
Reduced
303
Closed
63
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
$50.9M |
| 2 |
Procter & Gamble
PG
|
$26.1M |
| 3 |
Keysight
KEYS
|
$24.4M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$22.3M |
| 5 |
Bristol-Myers Squibb
BMY
|
$20.5M |
Top Sells
| 1 |
ManpowerGroup
MAN
|
$744M |
| 2 |
CELG
Celgene Corp
CELG
|
$45.1M |
| 3 |
Exxon Mobil
XOM
|
$36.1M |
| 4 |
ARRY
Array Biopharma Inc
ARRY
|
$28.3M |
| 5 |
Walt Disney
DIS
|
$26.8M |
Sector Composition
| 1 | Healthcare | 33.22% |
| 2 | Technology | 16.94% |
| 3 | Financials | 10.4% |
| 4 | Consumer Discretionary | 9.11% |
| 5 | Communication Services | 7.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Emerson Electric
EMR
$72.5B
| $22.5M | 0.28% |
338,654
-207,045
| -38% | -$13.8M |
|
77
Bio-Techne
TECH
$8.3B
| $22.4M | 0.28% |
108,017
-400
| -0.4% | -$83K |
|
|
ATVI
78
DELISTED
Activision Blizzard Inc.
ATVI
| $22.3M | 0.28% |
473,561
-21,957
| -4% | -$1.03M |
|
79
Mercado Libre
MELI
$120B
| $21.7M | 0.27% |
35,629
-6,297
| -15% | -$3.84M |
|
|
SAGE
80
DELISTED
Sage Therapeutics
SAGE
| $21.6M | 0.27% |
118,300
-60,000
| -34% | -$10.9M |
|
|
BLUE
81
DELISTED
bluebird bio
BLUE
| $21.4M | 0.27% |
169,100
| – | – |
|
82
Elevance Health
ELV
$72.4B
| $21.3M | 0.27% |
75,757
+8
| +0% | +$2.25K |
|
83
Allstate
ALL
$53.6B
| $21.1M | 0.26% |
194,118
-53,853
| -22% | -$5.85M |
|
84
Dentsply Sirona
XRAY
$2.76B
| $20.5M | 0.26% |
353,645
+127,913
| +57% | +$7.43M |
|
85
PTC
PTC
$25.4B
| $20.4M | 0.25% |
227,965
+13,269
| +6% | +$1.19M |
|
86
NVIDIA
NVDA
$4.12T
| $20.4M | 0.25% |
124,583
-2,362
| -2% | -$386K |
|
87
Estee Lauder
EL
$32.8B
| $20.3M | 0.25% |
111,482
+14,135
| +15% | +$2.58M |
|
88
Eli Lilly
LLY
$659B
| $20.2M | 0.25% |
183,054
+2,050
| +1% | +$226K |
|
|
SGEN
89
DELISTED
Seagen Inc. Common Stock
SGEN
| $20M | 0.25% |
289,780
+2,911
| +1% | +$201K |
|
|
BHVN
90
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $20M | 0.25% |
457,799
+15,000
| +3% | +$654K |
|
91
Applied Materials
AMAT
$123B
| $19.8M | 0.25% |
414,281
-273,848
| -40% | -$13.1M |
|
92
Credicorp
BAP
$20.7B
| $19.7M | 0.25% |
86,500
-9,200
| -10% | -$2.1M |
|
93
Mondelez International
MDLZ
$79.3B
| $19.1M | 0.24% |
309,491
+67,064
| +28% | +$4.14M |
|
94
Comcast
CMCSA
$125B
| $19.1M | 0.24% |
453,147
-56,587
| -11% | -$2.38M |
|
|
BZUN
95
Baozun
BZUN
$230M
| $19.1M | 0.24% |
384,000
-256,000
| -40% | -$12.7M |
|
96
Zimmer Biomet
ZBH
$20.7B
| $19M | 0.24% |
162,338
+50,860
| +46% | +$5.96M |
|
97
Ionis Pharmaceuticals
IONS
$9.59B
| $18.8M | 0.23% |
293,200
-100,000
| -25% | -$6.4M |
|
98
MetLife
MET
$53.4B
| $18.7M | 0.23% |
347,250
-44,896
| -11% | -$2.42M |
|
99
Labcorp
LH
$22.7B
| $18.5M | 0.23% |
107,438
+10,485
| +11% | +$1.8M |
|
100
Monster Beverage
MNST
$61.9B
| $18.3M | 0.23% |
287,994
+102,996
| +56% | +$6.55M |
|